PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · UrologyMedium impact

Prostatic Urethral Lift

Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

Use of prostatic urethral lift in individuals with moderate-to-severe lower urinary tract obstruction due to benign prostatic hyperplasia may be considered medically necessary when all of the listed criteria are met. Use of prostatic urethral lift in other situations, including repeat procedures, is considered investigational.

Get alerts when payers change rules like this one

We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.

What to do

Action · 7 steps
01Billing team: Before billing CPT 52441 or 52442, or HCPCS C9739 or C9740, document that all of the criteria are met.
02The criteria are persistent or progressive lower urinary tract symptoms despite medical therapy (alpha-1 adrenergic antagonists maximally titrated, 5-alpha reductase inhibitors, or combination medication therapy maximally titrated) over a trial period of no less than 6 months, or inability to tolerate medical therapy; prostate gland volume of 80 mL or less; normal bladder neck without an obstructive or protruding median lobe; no acute urinary retention related to conditions other than benign prostatic hyperplasia, urinary tract infection, or recent prostatitis within the past year; appropriate testing to exclude prostate cancer; and no known allergy to nickel, titanium, or stainless steel.
03These codes are listed as medically necessary only when the procedure is performed according to the Policy section.
04BCBSMS makes no payment for services not documented to be medically necessary.
05Repeat procedures are considered investigational.
06Check the member's specific benefit plan language, because the coverage guidelines should not be used in lieu of it.
07For Federal Employee Program members, FDA-approved devices, drugs or biologics may not be considered investigational and may be assessed only on the basis of medical necessity.

Codes mentioned

5244152442C9739C9740N40.1N40.3

Original notice

Prostatic Urethral Lift
bcbsms.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account